Comprehensive Pathophysiology of Myocardial Ischemia and Injury Explained

Convert to note

Introduction to Myocardial Ischemia

Myocardial ischemia occurs when blood supply to the heart muscle is insufficient to meet its metabolic demands, primarily due to an imbalance between oxygen supply and demand. Dr. Vijay Shiragawan explains that ischemic heart disease (IHD), also known as coronary artery disease (CAD), results mainly from impaired coronary blood flow.

Coronary Blood Flow and Its Determinants

  • Unique Features: The heart extracts about 70% of oxygen from coronary blood at rest, requiring increased flow during higher demand.
  • Determinants:
    • Metabolic activity of myocardial cells releasing vasodilators like adenosine, potassium ions, lactic acid, and carbon dioxide.
    • Endothelial cell products including vasodilators (nitric oxide, prostacyclin) and vasoconstrictors (endothelin).
  • Influences on Flow:
    • Aortic pressure dynamics during systole and diastole.
    • Autoregulation adjusting vessel tone based on metabolic needs.
    • Compression of intramyocardial vessels during heart contraction, reducing subendocardial blood flow during systole.

Myocardial Oxygen Supply and Demand

  • Supply Factors: Coronary artery patency, diastolic filling time, and hemoglobin oxygen-carrying capacity.
  • Demand Factors: Heart rate, left ventricular contractility, and wall stress (preload and afterload).
  • Heart Rate Impact: Increased heart rate raises oxygen demand and reduces diastolic time, limiting coronary perfusion.
  • Contractility: Enhanced by sympathetic stimulation and inotropic agents, increasing oxygen consumption.
  • Wall Stress: Increased by ventricular dilation or high blood pressure, elevating oxygen demand.

Causes of Reduced Coronary Blood Flow Leading to Ischemia

  • Fixed coronary artery stenosis primarily due to atherosclerosis.
  • Acute changes like plaque rupture, hemorrhage, and thrombosis.
  • Vasoconstriction and coronary artery spasms.
  • Decreased aortic diastolic pressure and increased intraventricular pressure.
  • Valve diseases and elevated right atrial pressure.

Pathogenesis of Ischemic Heart Disease

  • Atherosclerosis: The main cause in over 90% of cases, involving:
    1. Endothelial dysfunction.
    2. Fatty streak formation in the intima.
    3. Migration of leukocytes and smooth muscle cells.
    4. Foam cell formation from macrophages ingesting lipids.
    5. Fibrosis and extracellular matrix degradation.
  • Inflammation: Plays a critical role at all stages, promoting plaque instability.
  • Thrombosis: Triggered by plaque rupture or erosion, causing acute coronary syndromes.
  • Vasospasm: Exacerbates ischemia, especially at sites of atherosclerotic stenosis.

Role of Oxidized LDL and Aging

  • Oxidized LDL induces endothelial dysfunction, promotes inflammation, foam cell formation, and plaque instability.
  • Aging contributes to endothelial damage, arterial stiffness, and a pro-inflammatory, hypercoagulable state, increasing ischemic risk.

Coronary Microvascular Dysfunction (CMD)

  • CMD causes increased resistance in small coronary vessels, leading to ischemia without large artery obstruction.
  • It is a key mechanism in type 2 myocardial infarction and microvascular angina.

Clinical Manifestations of Ischemic Heart Disease

  • Angina Pectoris: Chest pain due to transient ischemia without myocyte death.
  • Myocardial Infarction: Prolonged ischemia causing myocyte necrosis.
  • Chronic Ischemic Heart Disease: Progressive heart failure following repeated ischemic insults.
  • Sudden Cardiac Death: Often due to lethal arrhythmias.

Non-Ischemic Myocardial Injury

  • Acute or chronic myocardial injury can occur without ischemia, identified by elevated cardiac biomarkers.
  • Differentiation from ischemic injury is crucial, especially in type 2 myocardial infarction contexts.

Summary

Myocardial ischemia results from complex interactions between coronary blood flow and myocardial oxygen demand, with atherosclerosis as the predominant cause. Understanding the pathophysiology, including endothelial dysfunction, inflammation, thrombosis, and microvascular disease, is essential for diagnosis and management of ischemic heart disease.

For a deeper understanding of the underlying mechanisms, you may find the following resources helpful:

Heads up!

This summary and transcript were automatically generated using AI with the Free YouTube Transcript Summary Tool by LunaNotes.

Generate a summary for free
Buy us a coffee

If you found this summary useful, consider buying us a coffee. It would help us a lot!


Ready to Transform Your Learning?

Start Taking Better Notes Today

Join 12,000+ learners who have revolutionized their YouTube learning experience with LunaNotes. Get started for free, no credit card required.

Already using LunaNotes? Sign in